MithraGen


MithraGen develops immunotherapies for T and B cells for the treatment and prevention of cancers and infectious diseases. It offers RetroVax, a product platform technology, which turns antigen containing class I and II epitopes into an immunostimulant. The company also provides RetroVax therapeutics vaccines.

MithraGen develops immunotherapies for T and B cells for the treatment and prevention of cancers and infectious diseases. It offers RetroVax, a product platform technology, which turns antigen containing class I and II epitopes into an immunostimulan...Show all

Company (Alive / Active)

Phone: 713-842-6188

Fax:

8030 El Rio

Houston, 77054
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MithraGen $1.8M Jan 1, 2001

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MithraGen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)